Dynogen Pharmaceuticals, Inc. Obtains $3,999,900 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0e75600f-61b9-4378-98d4-2400bd66e838&Preview=1 -
Date
12/31/2007 -
Company Name
Dynogen Pharmaceuticals, Inc. -
Mailing Address
52 Second Avenue Waltham, MA 02451 -
Company Description
Dynogen Pharmaceuticals, Inc., is a neuroscience-based drug discovery and development company targeting first-in-class and best-in-class therapies for genitourinary and gastrointestinal disorders. -
Website
http://www.dynogenpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$3,999,900 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
HealthCare Ventures -
Venture Investor
Oxford Bioscience Partners -
Venture Investor
Undisclosed
